Rankings
▼
Calendar
BOLD Q3 2022 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$13M
Net Income
-$13M
EPS (Diluted)
$-0.59
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$596,000
← FY 2022
All Quarters
Q4 2022 →